Thrombolytic therapy in pulmonary embolism. Which patients should be treated, which regimen should be used?
Reference26 articles.
1. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI, Schwartz JS, Thompson BT, Popovich J, Hobbins TE, Spera MA, Alavi A, Terrin ML (1992) The clinical course of pulmonary embolism. N Engl J Med 326:1240–5
2. Dalla-Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visioli O, Zonzin P, Zanuttini D, Barbaresi F, Agnelli G, Morpugo M, Marini MG, Visani L (1992) Paims 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator italian multicenter study 2. J Am Coll Cardiol 20:520–526
3. Goldhaber SZ (1997) Pulmonary embolism thrombolysis. Broadening the paradigm for its administration. Circulation 96:716–718
4. Goldhaber SZ, Agnelli G, Levine MN (1994) Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. Chest 106:718–724
5. Goldhaber SZ, Feldstein ML, Sors H (1994) Two trials of reduced bolus alteplase in the treatment of pulmonary embolism. Chest 106:725–726